Literature DB >> 1715307

Fragile X expression and X inactivation. II. The fragile site at Xq27.3 has a basic function in the pathogenesis of fragile X-linked mental retardation.

D Wöhrle1, P Steinbach.   

Abstract

The major concept of fragile X pathogenesis postulates that the fragile site at band Xq27.3 [fra(X)] represents the primary defect. The expression of fra(X) is predicted to be an intrinsic property of the mutated chromosome and, hence, should not be suppressed by X inactivation in females or induced by X-linked trans-acting factors. We made fibroblast clones of a fra(X)-positive female. Monoclonality was demonstrated using the DNA methylation assay at DXS255. The mutated X chromosomes and their states of genetic activity in the different clones were also defined by molecular methods. Five clones were selected to induce expression of fra(X) by 10(-7) M FUdR; two carried an active mutated X chromosome, in the other three the mutated X chromosome was inactivated. Fra(X) was found expressed in both types of clones. The percentages of positive cells were as high as 7-10%, regardless of the genetic activity of the mutated X chromosomes. DNA replicating patterns, obtained by BUdR labelling, demonstrated that expression occurred only on the mutated X chromosomes previously identified by molecular methods. The concept that the fragile site represents the primary mutation is now strongly supported by experimental evidence. The expression of fra (X) in females is independent of X inactivation and other trans-acting factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715307     DOI: 10.1007/bf00197160

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Isolation and characterization of a human variable copy number tandem repeat at Xcen-p11.22.

Authors:  N J Fraser; Y Boyd; I Craig
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

3.  Fragile-X mutation proposed to block complete reactivation in females of an inactive X chromosome.

Authors:  C D Laird
Journal:  Am J Med Genet       Date:  1988 May-Jun

4.  Recombination and amplification of pyrimidine-rich sequences may be responsible for initiation and progression of the Xq27 fragile site: an hypothesis.

Authors:  R L Nussbaum; S D Airhart; D H Ledbetter
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

5.  Clinical features and reproductive patterns in fragile X female heterozygotes.

Authors:  D Z Loesch; D A Hay
Journal:  J Med Genet       Date:  1988-06       Impact factor: 6.318

6.  Multi-allelic RFLP for M27 beta, an anonymous single copy genomic clone at Xp11.3-Xcen [HGM9 provisional no. DXS255].

Authors:  N J Fraser; Y Boyd; G G Brownlee; I W Craig
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

7.  Expression of the fragile site Xq27 in fibroblasts. II. Evidence for negative and positive clones from heterozygous females and possible relationship between frequency and phenotype.

Authors:  P Steinbach; G Barbi; S Baur; W Vogel
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Further segregation analysis of the fragile X syndrome with special reference to transmitting males.

Authors:  S L Sherman; P A Jacobs; N E Morton; U Froster-Iskenius; P N Howard-Peebles; K B Nielsen; M W Partington; G R Sutherland; G Turner; M Watson
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Comparison of thymidine, fluorodeoxyuridine, hydroxyurea, and methotrexate blocking at the G1/S phase transition of the cell cycle, studied by replication patterns.

Authors:  W Vogel; W Schempp; I Sigwarth
Journal:  Hum Genet       Date:  1978-12-18       Impact factor: 4.132

10.  Effects of nucleotides on expression of the folate sensitive fragile sites.

Authors:  G R Sutherland; E Baker
Journal:  Am J Med Genet       Date:  1986 Jan-Feb
View more
  4 in total

1.  A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome.

Authors:  D Wöhrle; D Kotzot; M C Hirst; A Manca; B Korn; A Schmidt; G Barbi; H D Rott; A Poustka; K E Davies
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

2.  Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families.

Authors:  M Milà; H Kruyer; G Glover; A Sánchez; P Carbonell; S Castellví-Bell; V Volpini; J Rossell; J Gabarrón; I López
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

3.  Genotype mosaicism in fragile X fetal tissues.

Authors:  D Wöhrle; M C Hirst; I Kennerknecht; K E Davies; P Steinbach
Journal:  Hum Genet       Date:  1992-04       Impact factor: 4.132

4.  Molecular analysis of mutations in the gene FMR-1 segregating in fragile X families.

Authors:  P Steinbach; D Wöhrle; G Tariverdian; I Kennerknecht; G Barbi; H Edlinger; H Enders; M Götz-Sothmann; H Heilbronner; D Hosenfeld
Journal:  Hum Genet       Date:  1993-11       Impact factor: 4.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.